Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
German Treatment Optimization Study for Children with De Novo and Relapsed Langerhans Cell Histiocytosis (LCH-IV, Germany)
DRKS00012701Phase 3Recruiting
- Sponsor
- Goethe University Frankfurt
- Start
- Nov 2017
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules, Nucleic Acid-Directed Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised trial of prednisone, vinblastine, mercaptopurine, methotrexate and indomethacin in Langerhans cell histiocytosis (LCH) (7 arms), sponsored by Goethe University Frankfurt. Started Nov 2017; status: recruiting.
02
Drugs
prednisonevinblastinemercaptopurinemethotrexateindomethacin
03
Conditions
Langerhans cell histiocytosis (LCH)
Beyond the preview
Go deeper on DRKS00012701.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on DRKS00012701.